Beacon Harbor Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Beacon Harbor Wealth Advisors's PFE Position: Q1 2026 in Review
Beacon Harbor Wealth Advisors increased its Pfizer (PFE) stake by 180% in Q1 2026, buying an estimated $5.18M and bringing the position to 302,840 shares worth $8.5M. The position accounts for 1.78% of the portfolio, ranked #21.
Beacon Harbor Wealth Advisors first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Beacon Harbor Wealth Advisors held 302,840 shares of Pfizer worth $8.5M as of Q1 2026.
- Beacon Harbor Wealth Advisors bought 194,544 Pfizer shares in Q1 2026, an estimated $5.18M.
- Pfizer made up 1.78% of Beacon Harbor Wealth Advisors's portfolio in Q1 2026, its #21 holding.
- Beacon Harbor Wealth Advisors first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Beacon Harbor Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.